Delivery Order SPE2DE24D0013-SPE2D625F8QV3
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. for the supply of XPert Xpress COVID-19, Influenza, and RSV molecular diagnostic test kits. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 10, 2025, represents a routine procurement under Cepheid's existing federal contract vehicles. The work will be performed at Cepheid's facility in Sunnyvale,...
- The Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $9,520 to Cepheid Inc. for the supply of COVID-19/Flu/RSV diagnostic test kits (10 tests per kit). This firm fixed-price delivery order, issued on October 6, 2025, with an ultimate completion date of October 14, 2025, carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. This delivery order likely draws from one of Cepheid's existing...
- The Defense Logistics Agency (Defense organization under the Medical Supply Chain) awarded a $16.3K firm fixed-price delivery order to Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic test kit (10-test viral test kit) on July 23, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and represents a routine procurement of molecular diagnostic testing solutions...
- The Defense Logistics Agency's Medical Supply Chain branch awarded a $34,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer based in Sunnyvale, California, for 10 tests of a COVID-19/Influenza/RSV diagnostic kit. The contract, issued on May 29, 2025, is scheduled for completion by June 6, 2025, with performance taking place in Sunnyvale. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing support to federal...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $13,980 to Cepheid Inc. for COVID-19/Influenza/RSV diagnostic test kits on August 8, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents procurement of molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer. The delivery order will be performed at Cepheid's Sunnyvale facility. This...
- The Defense Logistics Agency Medical Supply Chain awarded a $10.2K firm fixed-price delivery order to Cepheid Inc. on July 22, 2025, for the XpertXpress COVID-19, Influenza, RSV, and Molecular Biology test kit. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will perform the work at its California facility. This delivery order carries no set-aside designation and represents a continuation of Cepheid's long-standing relationship supplying diagnostic...
- This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery...
- The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain function) awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The award reflects Cepheid's specialized expertise in providing rapid molecular diagnostic testing for...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8QV3Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $6.8K firm fixed-price delivery order to Cepheid for the provision of COVID-19/Influenza/RSV diagnostic test kits (10-test viral test kits). The contract, awarded on July 25, 2025, with an ultimate completion date of July 30, 2025, carries no set-aside designation. Performance of this delivery order will occur at Cepheid's facility in Sunnyvale, California. This award represents a discrete procurement action under the federal government's ongoing relationship with Cepheid for molecular diagnostic solutions supporting defense and military healthcare operations. Cepheid, a for-profit manufacturer of molecular diagnostic systems headquartered in Sunnyvale, California, specializes in infectious disease detection technologies and maintains established relationships with multiple federal healthcare agencies including the Department of Veterans Affairs and the Defense Health Agency. The company holds significant indefinite delivery vehicles with the VA worth over $35M collectively, positioning it as a key supplier of diagnostic reagents, assays, and testing systems across federal healthcare networks. This delivery order for multiplex respiratory viral testing kits aligns with Cepheid's core competency in providing rapid, point-of-care diagnostic solutions for infectious diseases including COVID-19, influenza, and RSV to military and defense medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 7/25/25 |